Elevated endothelial microparticle-monocyte complexes induced by multiple sclerosis plasma and the inhibitory effects of interferon-β1b on release of endothelial microparticles, formation and transendothelial migration of monocyte-endothelial microparticle complexes

Multiple Sclerosis

Volumn 11, Issue 3, 2005, Pages 310-315

  Jimenez, Joaquin J ^a   Jy, Wenche ^a   Mauro, Lucia M ^a   Horstman, Lawrence L ^a   Ahn, Eugene R ^a   Ahn, Yeon S ^a   Minagar, Alireza ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

Endothelial microparticle; Exacerbation; Interferon 1b; Monocyte; Multiple sclerosis; Remission

Indexed keywords

CD31 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERFERON BETA SERINE; PADGEM PROTEIN;

ADULT; ARTICLE; BRAIN BLOOD VESSEL; BRAIN CELL; CELL CULTURE; CELL JUNCTION; CELL MIGRATION; CELL SECRETION; CLINICAL ARTICLE; COMPLEX FORMATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DEMYELINATION; DISEASE EXACERBATION; DRUG MECHANISM; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; MALE; MONOCYTE; MULTIPLE SCLEROSIS; NEUROIMAGING; PARTICULATE MATTER; PATHOGENESIS; PHENOTYPIC VARIATION; REMISSION;

ADJUVANTS, IMMUNOLOGIC; ADULT; BLOOD-BRAIN BARRIER; CELL MOVEMENT; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INTERFERON-BETA; MAGNETIC RESONANCE IMAGING; MALE; MONOCYTES; MULTIPLE SCLEROSIS; PARTICLE SIZE; U937 CELLS;

EID: 20144381022     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/1352458505ms1184oa     Document Type: Article

References (35)

1. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med 2000; 343: 938-52.
2. Steinman L. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 1996; 85: 299-302.
3. Brosnan CF, Raine CS. Mechanisms of immune injury in multiple sclerosis. Brain Pathol 1996; 6: 243-57.
4. Prat A, Biernacki K, Lavoie JF, Poireir J, Duquette P, Antel JP. Migration of multiple sclerosis lymphocytes through brain endothelium. Arch Neurol 2002; 59: 391-97.
5. Hartung HP, Reiners K, Archelos JJ, Michels M, Seeldrayers P, Heidenreich F et al. Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: correlation with magnetic resonance imaging. Ann Neurol 1995; 38: 186-93.
6. Leppert D, Lindberg RL, Kappos L, Leib SL. Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis. Brain Res Brain Res Rev 2001; 36: 249-57.
7. The IFNb Multiple Sclerosis Study Group. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group. Neurology 1993; 43: 655-61.
8. Uhm JH, Dooley NP, Stuve O, Francis GS, Duquette P, Antel JP et al. Migratory behavior of lymphocytes isolated from multiple sclerosis patients: effects of interferon beta-1b therapy. Ann Neurol 1999; 46: 319-24.
9. Corsini E, Gelati M, Dufour A, Ciusani E, La Mantia L, Massa G et al. Reduction of transendothelial migration of mononuclear cells in interferon-beta1b-treated multiple sclerosis patients. Ann Neurol 1999; 46: 435.
10. Losy J, Niezgoda A, Wender M. Increased serum levels of soluble PECAM-1 in multiple sclerosis patients with brain gadolinium-enhancing lesions. J Neuroimmunol 1999; 99: 169-72.
11. Minagar A, Jy W, Jimenez JJ, Sheremata WA, Mauro LM, Mao WW et al. Elevated plasma endothelial microparticles in multiple sclerosis. Neurology 2001; 56: 1319-24.
12. Combes V, Simon AC, Grau GE, Arnoux D, Camoin L, Sabatier F et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest 1999; 104: 93-102.
13. Jimenez JJ, Jy W, Mauro LM, Soderland C, Horstman LL, Ahn YS. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res 2003; 109: 175-80.
14. Sabatier F, Roux V, Anfosso F, Camoin L, Sampol J, Dignat-George F. Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity. Blood 2002; 99: 3962-70.
15. Jy W, Minagar A, Jimenez JJ, Sheremata WA, Mauro LM, Horstman LL et al. Endothelial microparticles (EMP) bind and activate monocytes: elevated EMP-monocyte conjugates in multiple sclerosis. Front Biosci 2004; 9: 3137-44.
16. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
17. Jimenez JJ, Jy W, Mauro LM, Horstman LL, Ahn YS. Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease. Br J Haematol 2001; 112: 81-90.
18. Kermode AG, Thompson AJ, Tofts P, MacManus DG, Kendall BE, Kingsley DP et al. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. Brain 1990; 113: 1477-89.
19. Minagar A, Ostanin D, Long AC, Jennings M, Kelley RE, Sasaki M et al. Serum from patients with multiple sclerosis down-regulates occludin and VE-cadherin expression in cultured endothelial cells. Mult Scler 2003; 9: 235-38.
20. Minagar A, Long A, Ma T, Jackson TH, Kelley RE, Ostanin DV et al. Interferon (IFN)-beta 1a and IFN-beta 1b block IFN-gamma-induced disintegration of endothelial junction integrity and barrier. Endothelium 2003; 10: 299-307.
21. Jy W, Jimenez JJ, Minagar A, Mauro L, Horstmann LL, Bidot CJ et al. Endothelial microparticles (EMP) enhance adhesion and transmigration of monocytes: EMP-monocyte conjugates as a marker of disease activity in multiple sclerosis (MS). Blood 2002; 100: 460a.
22. Jy W, Jimenez JJ, Mauro L, Horstmann LL, Bernal-Mizrachi LL, Minagar A et al. Interaction of endothelial microparticles (EMP) with leukocytes: potential roles of EMP in thrombosis and inflammation. Blood 2001; 98: 226a.
23. Horstman LL, Jy W, Jimenez JJ, Ahn YS. Endothelial microparticles as markers of endothelial dysfunction. Front Biosci 2004; 9: 1118-35.
24. Stone LA, Frank JA, Albert PS, Bash C, Smith ME, Maloni H et al. The effect of interferon-beta on blood-brain barrier disruptions demonstrated by contrast-enhanced magnetic resonance imaging in relapsing-remitting multiple sclerosis. Ann Neurol 1995; 37: 611-19.
25. Calabresi PA, Tranquill LR, Dambrosia JM, Stone LA, Maloni H, Bash CN et al. Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon beta-1b. Ann Neurol 1997; 41: 669-74.
26. Dhib-Jalbut S, Jiang H, Williams GJ. The effect of interferon beta-1b on lymphocyte-endothelial cell adhesion. J Neuroimmunol 1996; 71: 215-22.
27. Floris S, Ruuls SR, Wierinckx A, van der Pol SM, Dopp E, van der Meide PH et al. Interferon-beta directly influences monocyte infiltration into the central nervous system. J Neuroimmunol 2002; 127: 69-79.
28. Corsini E, Gelati M, Dufour A, Massa G, Nespolo A, Ciusani E et al. Effects of beta-IFN-1b treatment in MS patients on adhesion between PBMNCs, HUVECs and MS-HBECs: an in vivo and in vitro study. J Neuroimmunol 1997; 79: 76-83.
29. Sorensen TL, Roed H, Sellebjerg F. Chemokine receptor expression on B cells and effect of interferon-beta in multiple sclerosis. J Neuroimmunol 2002; 122: 125-31.
30. Iarlori C, Reale M, De Luca G, Di Iorio A, Feliciani C, Tulli A et al. Interferon beta-1b modulates MCP-1 expression and production in relapsing-remitting multiple sclerosis. J Neuroimmunol 2002; 123: 170-79.
31. Zang YC, Halder JB, Samanta AK, Samanta AK, Hong J, Rivera VM, Zhang JZ. Regulation of chemokine receptor CCR5 and production of RANTES and MIP-1alpha by interferon-beta. J Neuroimmunol 2001; 112: 174-80.
32. Waubant E, Goodkin D, Bostrom A, Bacchetti P, Hietpas J, Lindberg R et al IFNbeta lowers MMP-9/TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMS. Neurology 2003; 60: 52-57.
33. Romanic AM, White RF, Arleth AJ, Ohlstein EH, Barone FC. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 1998; 29: 1020-30.
34. Stuve O, Chabot S, Jung SS, Williams G, Yong VW. Chemokine-enhanced migration of human peripheral blood mononuclear cells is antagonized by interferon beta-1b through an effect on matrix metalloproteinase-9. J Neuroimmunol 1997; 80: 38-46.
35. Jy W, Delgado S, Minagar A, Ahn Y, Sheremata W. Interferon-β1a reduces plasma CD31+ endothelial microparticles in MS. Ann Neurol 2003; 54: S60.